Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced today a new ...

I’d rather be at home doing it for myself.” Boynton used the self-injectable version of Depo-Provera for nearly 2 years and ...

New findings from a Phase II study indicate that antenatal treatment with the FcRn blocker nipocalimab resulted in low fetal drug exposure and transient reductions in infant IgG levels at birth, ...

In Bayer’s new “Life Doesn’t Stop for a Hot Flash” campaign, Gabrielle Union-Wade discusses her personal experiences with ...

Lindsay Feldman had given up hope of having any more children. Then the 39-year-old started taking a popular weight-loss drug - and just ten months later she was pregnant.

Miami, Florida / Syndication Cloud / January 23, 2026 / Trybello LLC Key Takeaways Female pattern hair loss affects about 12% ...

Brothers Mohamed Duklef, 36, and Hani Duglof, 32, came to the U.S. from their home country, Libya, in 2014, looking for a ...

Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for ...

By Julia Vitarello MHRA forewordMila's story is one of the most powerful you will ever read. It is both heart-breaking and also inspiring when you ...

Tech billionaire Elon Musk announced the next-gen Neuralink chips. Plus, first trials for Blindsight augmentation are also on their way.

It was long believed that men wouldn't reliably use birth control, but many are signing up for clinical trials of ...

Meanwhile, the U.K.'s Medicines and Healthcare Products Regulatory Agency updated its warnings on GLP-1 and dual GLP-1/GIP ...